Your browser doesn't support javascript.
loading
Intratumoral Activity of the CXCR3 Chemokine System Is Required for the Efficacy of Anti-PD-1 Therapy.
Chow, Melvyn T; Ozga, Aleksandra J; Servis, Rachel L; Frederick, Dennie T; Lo, Jennifer A; Fisher, David E; Freeman, Gordon J; Boland, Genevieve M; Luster, Andrew D.
Afiliación
  • Chow MT; Center for Immunology & Inflammatory Diseases, Division of Rheumatology, Allergy & Immunology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA.
  • Ozga AJ; Center for Immunology & Inflammatory Diseases, Division of Rheumatology, Allergy & Immunology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA.
  • Servis RL; Center for Immunology & Inflammatory Diseases, Division of Rheumatology, Allergy & Immunology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA.
  • Frederick DT; Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA.
  • Lo JA; Cutaneous Biology Research Center, Department of Dermatology and MGH Cancer Center, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA.
  • Fisher DE; Cutaneous Biology Research Center, Department of Dermatology and MGH Cancer Center, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA.
  • Freeman GJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA.
  • Boland GM; Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA.
  • Luster AD; Center for Immunology & Inflammatory Diseases, Division of Rheumatology, Allergy & Immunology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA. Electronic address: aluster@mgh.harvard.edu.
Immunity ; 50(6): 1498-1512.e5, 2019 06 18.
Article en En | MEDLINE | ID: mdl-31097342
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Receptores CXCR3 / Inmunomodulación / Receptor de Muerte Celular Programada 1 / Antineoplásicos Inmunológicos / Neoplasias Límite: Animals / Humans Idioma: En Año: 2019 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Receptores CXCR3 / Inmunomodulación / Receptor de Muerte Celular Programada 1 / Antineoplásicos Inmunológicos / Neoplasias Límite: Animals / Humans Idioma: En Año: 2019 Tipo del documento: Article